Anel Berna,Luis Alberto | Leucemia | Innovative Research Award

Published on by Oncology

Innovative Research Award

Luis Alberto Anel Bernal
University of Zaragoza, Spain

Luis Alberto Anel Bernal
Affiliation University of Zaragoza
Country Spain
Google Scholar ID View Profile
Documents 220
Citations 26,035
h-index 56
Subject Area Leucemia
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0002-5175-8394

The Innovative Research Award recognizes distinguished academic researchers whose scholarly activities have significantly contributed to scientific advancement within their respective disciplines. Luis Alberto Anel Bernal of the University of Zaragoza has established an internationally recognized research profile through sustained contributions to leukemia research, translational biomedical science, and interdisciplinary collaboration. His scholarly output reflects a commitment to advancing knowledge through rigorous experimentation, evidence-based methodologies, and international scientific cooperation.[1]

Abstract

Luis Alberto Anel Bernal is recognized for his extensive scientific contributions to leukemia and oncology research through high-impact publications, collaborative investigations, and translational biomedical studies. His research combines molecular biology, clinical investigation, and innovative therapeutic approaches to improve understanding of hematological malignancies. The measurable influence of his scholarly work is reflected through a substantial number of peer-reviewed publications, international collaborations, and a citation record demonstrating long-term academic relevance. These achievements support recognition through the Innovative Research Award as an acknowledgment of sustained scientific excellence and impactful research contributions.[1]

Keywords

Leukemia Research, Cancer Biology, Translational Medicine, Biomedical Science, Oncology, Clinical Research, Scientific Innovation, Molecular Biology, Hematological Malignancies, Precision Medicine, Therapeutic Development, International Collaboration.

Introduction

Modern oncology increasingly depends upon interdisciplinary collaboration, advanced molecular research, and evidence-based clinical investigation to improve patient outcomes. Researchers who consistently contribute high-quality scientific discoveries play an essential role in expanding medical knowledge and supporting the development of innovative therapeutic strategies. Luis Alberto Anel Bernal has participated extensively in this evolving research landscape through decades of scholarly activity focused on leukemia and related biomedical disciplines.[2]

Research Profile

Luis Alberto Anel Bernal is affiliated with the University of Zaragoza, Spain, where he has established an internationally recognized academic career in biomedical sciences with particular emphasis on leukemia research and oncology. His scientific activities encompass experimental investigation, translational medicine, molecular biology, and interdisciplinary collaboration aimed at improving the understanding of cancer development and therapeutic interventions. His academic profile reflects continuous participation in high-quality research initiatives and international scientific partnerships.[1]

Research Contributions

Professor Bernal has contributed significantly to advancing knowledge in leukemia biology through studies investigating molecular signaling pathways, disease progression, cellular regulation, and mechanisms associated with cancer development. His research combines laboratory experimentation with clinically relevant applications, allowing scientific discoveries to support improvements in diagnostic procedures and therapeutic strategies.[4]

Publications

The scholarly publication portfolio of Luis Alberto Anel Bernal demonstrates consistent productivity across peer-reviewed international journals. His publications address diverse aspects of leukemia, oncology, molecular medicine, and biomedical research while contributing valuable scientific evidence to the broader medical literature. The cumulative impact of these publications is reflected through extensive citation activity and continued relevance within contemporary cancer research.[2]

Research Impact

The scientific contributions of Luis Alberto Anel Bernal have generated substantial international academic recognition through a sustained record of peer-reviewed publications and scholarly citations. His work has influenced numerous studies within leukemia research, cancer biology, translational medicine, and molecular oncology. The extensive citation count demonstrates that his research continues to serve as an important scientific resource for investigators, clinicians, and graduate researchers working in oncology-related disciplines.[2]

Award Suitability

The Innovative Research Award recognizes researchers whose sustained scientific excellence has significantly advanced their discipline through impactful research, international collaboration, and measurable scholarly influence. Based on publicly available academic indicators, Luis Alberto Anel Bernal demonstrates these characteristics through his extensive publication record, citation performance, and continued contributions to leukemia and oncology research.[1]

Conclusion

Luis Alberto Anel Bernal has established a distinguished academic profile characterized by consistent scholarly productivity, extensive international collaboration, and substantial scientific impact within leukemia research. His work continues to support advances in biomedical science while contributing valuable knowledge to the global oncology community. The breadth of his research achievements and sustained academic influence make him an appropriate candidate for recognition through the Innovative Research Award.[3]

References

  1. Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S, Anel, A. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1–382.
    https://doi.org/10.1080/15548627.2020.1797280
  2. Martínez-Lostao, L., Anel, A., & Pardo, J. (2015). How do cytotoxic lymphocytes kill cancer cells? Clinical Cancer Research, 21(22), 5047–5056.
    https://doi.org/10.1158/1078-0432.CCR-15-0685
  3. Richieri, G. V., Anel, A., & Kleinfeld, A. M. (1993). Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry, 32(29), 7574–7580.
    https://pubmed.ncbi.nlm.nih.gov/8338853/
  4. De Miguel, D., Lemke, J., Anel, A., Walczak, H., & Martínez-Lostao, L. (2016). Onto better TRAILs for cancer treatment. Cell Death & Differentiation, 23(5), 733–747.
    https://doi.org/10.1038/cdd.2015.174
  5. Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., & Piñeiro, A. (1999). Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. The Journal of Immunology, 163(3), 1274–1281.
    https://pubmed.ncbi.nlm.nih.gov/10415024/

 

Sanaz Alaeejahromi | Reproductive Cancer | Best Researcher Award

Published on by Oncology

Dr. Sanaz Alaeejahromi | Reproductive Cancer | Best Researcher Award

Assistant Professor | Shiraz University of Medical Sciences | Iran 

Dr. Sanaz Alaee is an accomplished reproductive biologist and clinical embryologist whose extensive academic, clinical, and research contributions make her an exceptional candidate for a Best Researcher Award. With over a decade of experience, she has built a distinguished career spanning reproductive toxicology, infertility treatment, ART technologies, and stem cell–based therapeutics. Her academic foundation includes a top-ranked PhD in Reproductive Biology, followed by faculty service at Shiraz University of Medical Sciences, where she has led the Reproductive Biology Department, directed the Reproductive Biology Lab, and currently serves as Director of the IVF Laboratory at Hazrat Zeinab Educational Medical Center. Her research portfolio is substantial, with more than 30 peer-reviewed publications covering critical topics such as implantation failure, ovarian and testicular toxicology, stem cell secretome therapy, PCOS biomarkers, assisted reproductive technologies, and oocyte/follicle maturation. A major highlight of her recent work includes a nationally funded project exploring extracellular vesicles from Wharton’s jelly mesenchymal stem cells for restoring fertility after chemotherapy—a promising direction for male infertility, especially among cancer survivors. She is internationally engaged, collaborating with researchers from the USA, UK, Australia, India, South Korea, Taiwan, UAE, and Kazakhstan, and remains active in global societies such as ESHRE, through which she is a certified Clinical Embryologist. Her editorial and peer-review influence is exemplary, with over 400 peer-reviews for high-impact journals, including Reproductive Sciences, Reproductive Toxicology, Scientific Reports, and PLOS ONE, demonstrating her commitment to scientific rigor and research integrity. Dr. Alaee has also contributed extensively to graduate education, curriculum development, and the supervision of MSc and PhD candidates. Her combined achievements in research innovation, clinical excellence, international collaboration, leadership, and scholarly service reflect a sustained and impactful contribution to reproductive biology, strongly supporting her suitability for a Best Researcher Award.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate 

Featured Publications

  1. Monsefi, M., Alaee, S., Moradshahi, A., & Rohani, L. (2010). Cadmium‐induced infertility in male mice. Environmental Toxicology: An International Journal, 25(1), 94–102.

  2. Fazeli, M., Hassanzadeh, P., & Alaei, S. (2011). Cadmium chloride exhibits a profound toxic effect on bacterial microflora of the mice gastrointestinal tract. Human & Experimental Toxicology, 30(2), 152–159.

  3. Neisy, A., Zal, F., Seghatoleslam, A., & Alaee, S. (2019). Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS). Reproduction, Fertility and Development, 31(2), 315–323.

  4. Alaee, S. (2017). Role of essential oil of Mentha spicata (spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model. Advanced Pharmaceutical Bulletin, 7(4), 651–654.

  5. Kargar-Abarghouei, E., Vojdani, Z., Hassanpour, A., Alaee, S., & others. (2018). Characterization, recellularization, and transplantation of rat decellularized testis scaffold with bone marrow-derived mesenchymal stem cells. Stem Cell Research & Therapy, 9(1), 324.

Dr. Alaee’s work advances reproductive science by integrating stem-cell therapies, toxicology insights, and cutting-edge ART technologies to improve fertility outcomes. Her research directly contributes to societal well-being by offering new hope for cancer survivors and infertile couples.